Thesis Overview
Dystonia is one of the most common movement
disorders in which abnormal, repetitive muscle contractions occur,
frequently causing twisting movements or incorrect body posture [
1].
The pathogenesis of primary dystonia is not fully understood. Although
neuropathologic studies did not reveal consistent abnormalities,
electrophysiologic and neuroimaging findings point towards disinhibition
and overactivity of the frontal motor cortical areas caused by an
altered basal ganglia outflow [
2,
3].
The probable cause is the dysfunction within neuronal circuits
involving subcortical nuclei, thalamus, motor cortex and cerebellum [
4-
7].
The relative contribution of specific neurotransmitters and pathways is
intensively studied but has not been established yet [
8-
11].
One of the proposed pathomechanisms is the deficiency or dysfunction of
ATP-dependent Menkes protein responsible for the extracellular
transport of copper within subcortical nuclei, the lack of which could
lead to increased accumulation of copper in the lenticular nucleus [
12-
14].
Accordingly, decreased levels of mRNA for Menkes protein and reduced
copper concentrations were found in peripheral blood lymphocytes of
patients with cervical dystonia [
15]. Other hypotheses emphasize the effect of concomitant moderate accumulation of manganese [
13,
16].
Primary dystonia is diagnosed based on medical history,
neurological examination and lack of observable brain abnormalities on neuroimaging [
17].
Specificity of diagnosis is impeded, however, by the lack of biological
marker. The usefulness of transcranial sonography (TCS) in the
detection of structural abnormalities within basal ganglia was shown for
the first time in 1995, when Becker et al. [
18] reported on specific abnormalities within substantia nigra of patients with
Parkinson disease (PD). Neuman [
4]
was the first to report ultrasonographic changes of lenticular nucleus
in idiopathic dystonia in 1996. Since then, TCS of subcortical nuclei
has become an active field of research. Based on previous literature and
present results we now hypothesize that LN hyperechogenicity may be an
ultrasound feature of all cervical dystonia.
The objective of our study was therefore to evaluate the prevalence
of hyperechogenic changes in lenticular nucleus of the brain in patients
with cervical dystonia.
Research Methodology
The
case-control study included patients with primary cervical dystonia and
a control group of healthy volunteers. Patients were recruited from
subjects treated between 2012 and 2017 in the Department of Neurology.
All patients were diagnosed with primary cervical dystonia in accordance
with the guidelines of European Federation of Neurological Society
(EFNS) [
17].
Healthy volunteers were recruited from inpatients and outpatients of
our clinic and included neurologically normal persons, without signs and
symptoms of movements or postural abnormalities, and without a history
of neurological disease.
We excluded all individuals with a history of vascular, metabolic or
traumatic injuries of central nervous system, patients with the history
of perinatal health problems, those with abnormal
neuroimaging
results, patients with suspected drug-induced dyskinesia and those with
opacity of temporal windows. One-hundred and eight patients were
considered eligible for inclusion; 42 of them were subsequently excluded
due to above-mentioned reasons. Thus, the study involved 66 patients
and 71 controls. The study was conducted in accordance with the Helsinki
Declaration and the study protocol was approved by the Local Ethics
Committee. Each participant signed a consent form to participate in the
study. The severity of dystonia was assessed clinically with the Toronto
Western Spasmodic Torticollis Rating Scale (TWSTRS). Each patient had
performed complete blood count, blood chemistry, as well as serum
concentration of ceruloplasmin, ferritin, copper and iron. Either
magnetic resonance imaging or computed tomography was also performed in
each patient.
Ultrasound examinations were conducted during routine visits of
patients who were treated with botulinum toxin within the treatment
programme of the National Health Fund. Ultrasound assessment of
subcortical brain structures was performed by a neurologist holding 10
years of experience in the field of transcranial ultrasound examinations
and blinded to the relevant clinical data. The ultrasound examination
was performed in a separate room with the use of Aloca Alpha Prosound 6
and according to the procedure recommended by the European Society of
Neurosonology and Cerebral Hemodynamics of May 2004 [
19,
20].
The examination was carried out bilaterally through the parotid
temporal windows determined by connecting the top of the orbit and the
upper end of the auricle. A 2.3 MHz probe was used, with a
maximum penetration depth of 14-16 cm from the temporal bone window, so
as to obtain the midbrain cross section (butterfly-shaped image) and the
cross section of hyperechogenic adjacent structures of the basal
cisterns. The obtained scan was enlarged twice and then, after manual
selection, automatic ipsilateral measurement of the surface area of
substantia nigra was performed. Hyperechogenicity of substantia nigra
was defined as an area equal to or larger than 0.20 cm2 [
20].
Similarly, in the horizontal projection of the third ventricle, a
contralateral surface area measurement of hyperechogenic changes in the
structures of the lenticular nucleus was made. Hyperechogenic changes
were defined as areas of echogenicity which was similar or increased in
comparison with the perimesencephalic cisterns [
20].
Measurement of obtained hyperechogenic structures in the lenticular
nucleus, as in the case of the substantia nigra, was selected manually,
while surface area measurement was performed automatically.
Statistical Analysis
In
order to select an adequate statistical test for the comparison of the
studied groups, the Kolomogorov-Smirnov test will be performed. In cases
where the test results indicated deviations from the normal
distribution, the Mann-Whitney U test was used and a nonparametric
alternative to the analysis of variance in the form of Kruskal-Wallis
test with the Dunn post-hoc test was used. In cases when the test
results indicate that the tested sample meets the conditions for normal
distribution and homogeneity of variance, the student’s t-test and ANOVA
analysis were used, and also post-hoc type comparisons, if necessary:
NIR test. The correlation strength was assessed using the R Sperman
coefficient. The highest reliability credibility chi- square was also
used.
Analyses were performed using the statistical software package,
STATISTICA 13 Dell Inc. Results with P value < 0.05 were considered
statistically significant. Pearson’s correlation coefficient was
calculated to determine potential correlations between region of LN
hyperechogenicity and duration of the disease, TWSTRS scale, the
duration of treatment or the age of patients and between the width of
third ventricle and the age of patients. Test Z was used for 2
population proportions.
Results
Finally,
from among the 108 patients, after excluding patients who did not meet
the inclusion criteria, 66 patients with primary cervical dystonia were
admitted to the study. The control group consisted of 71 people. The
average age of patients was 52,84 ± 14,45, in the control group: 53,52 ±
14,35; range: 20-80. The duration of the disease was 10,71 ± 10,45
years; women dominated in the material: 2,1:1 in the dystonia group and
1.6:1 in the control group (
Table 1). No statistical
differences were found between both groups (p=0.88). The clinical image
of movement disorders assessed by means of the TWSTRS scale in the group
of patients was on average 28.21 (SD ± 13.59) and for individual
components of the TWSTRS was as follows: Part I: 14.08 (SD ± 5.93), Part
II: 10.10 (SD ± 6.71), Part III: 4.08 (SD ± 3.86). In the case of all
patients, dystonia was stationary in nature and the observed
fluctuations of severity of symptoms accounted for the effect of BTX
treatment. The patients were treated with BTX for 5.8 years on average
(SD ± 4.9; range: 1-20 years) and most of them showed significant
improvement after BTX treatment.
Variables
Patient with cervical dystonia (n=66)
Control group
(n=71)
Age (years); mean (SD)
52.84 (14.45)
53.52 (14.04)*
Sex women/men (n)
45/21
60/11*
Disease duration (years); mean (SD)
10.71 (10.45)
-
Severity of dystonia (TWSTRS score); mean (SD) Total
28.21 (13.58)
-
Part I
14.08 (5.9)
-
Part II
10.10 (6.71)
-
Part III
4.08 (3.86)
-
SD:Standard Deviation; TWSTRS: Toronto Western Spasmodic Torticollis Rating Scale p>0.005.
Table 1: Comparison of age and sex between patients
with cervical dystonia and controls as well as clinical characteristics
of dystonia in studied patients.
Age and sex ratios of 66 patients and 71 controls, as well as
clinical characteristics of dystonia (duration of the disease and
severity of dystonia assessed with TWSTRS scale) are provided in
Table 2.
It was unilateral in majority of patients (75.76%). Hyperechogenicity
of the right lenticular nucleus was more often seen in patients with
head rotation to the left (p>0.01) but no other association between
the direction of dystonic movement and location of changes was observed,
although the hyperechogenicity contralateral to the direction of
rotational dystonic movement was more common in absolute values.
Hyperechogenic changes in lenticular nucleus were found in 8 controls
(11.27%); they were unilateral in all cases.
Hyperechogenicity
Dystonic patient with head rotation to right
(n=23)
Dystonic patient with head rotation to the left
(n=43)
p- value (test Z)
All patient with cervical dystonia
(n=66)
Control group (n=71)
p-value (test Z)
Right lenticular nucleus
12 (52.17)
24 (55.81)
0.77
36 (54.55)
4 (5.63)
<0.0001
Left lenticular nucleus
9 (39.13)
13 (30.23)
0.46
22 (33.33)
4 (5.63)
<0.0001
Both lenticular nuclei
5 (21.73)
3 (6.97)
0.079
8 (12.12)
0
<0.0001
Any location
17 (73.91)
33 (76.74)
0.79
50 (75.76)
8 (11.27)
<0.0001
None
6 (26.09)
10 (23.25)
0.79
16 (24.24)
63 (88.73)
<0.0001
Test Z for 2 population proportions.
*Data shown as number (%).
Table 2: Prevalence of hyperechogenic changes among
patients with cervical dystonia (including patients with head rotation
either to the left or to the right) and control subjects.
Hyperechogenicity of the lenticular nucleus was found more often in
patients with cervical dystonia than in controls.
Average SN surface area in cervical dystonia was 0.10 ± 0.08 cm² on
the right side and 0.09 ± 0.05 cm² on the left side, and average SN
surface area in control group was 0.08 ± 0.03 cm² on both side
(p>0.005). The surface area of the hyperechogenic changes was
respectively 0.10 ± 0.12 cm² on the right side and 0.05 ± 0.10 cm² on
the left side and they were significantly different from the changes
observed in the control group with 0.004 ± 0.02 cm² on the right side
and 0.005 ± 0.025 cm² on the left side (
Table 3).
Variables
Patient with cervical dystonia (n=66)
Control group
(n=71)
P-value
Mean
SD
Mean
SD
Age (years)
52 .84
14 .44
53 .52
14 .03
0 .88
Left substantianigra (cm2)
0 .09
0 .05
0 .08
0 .03
0 .10
Right substantianigra (cm2)
0 .10
0 .08
0 .08
0 .03
0 .43
Third ventricle width (mm)
4 .7
1 .48
4 .1
1 .29
0 .48
Hyperechogenicity of left lenticular nucleus (cm2)
0 .05
0 .10
0 .005
0 .02
0 .008
Hyperechogenicity of right lenticular nucleus (cm2)
0 .10
0 .12
0 .004
0 .019
0 .000029
U-Mann test
Table 3: Measurement of the surface of the
substantia nigra . surface of changes in the lenticular nucleus and the
width of the third ventricles in patients with cervical dystonia and in
the control group.
Table 3 provides data on surface areas of lenticular
nuclei and substantia nigra, as well as on third ventricle width among
patients with cervical dystonia (including subgroups of men and women)
and in control group. Surface area of the lenticular nuclei, either left
or right, was greater in patients with dystonia than in controls. The
surface area of the substantia nigra in one control subject was a
boderline value (0.20 cm²). This person appeared to have a positive
family history of
neurodegenerative
diseases. Measurements of the width of the third ventricle showed no
significant difference between the groups (p=0.48). No correlation was
found between hyperechogenicity of lenticular nucleus and the duration
of the disease, the severity of dystonia measured with the TWSTRS scale,
the duration of treatment or the age of patients. The width of third
ventricle correlated with the age of patients (r=0.39; p<0.01).
Discussion
We
have shown that hyperechogenic changes in the lenticular nucleus are
more prevalent in patients with primary cervical dystonia than in
healthy controls. The change was not related with severity, duration of
dystonia and any correlation was between hyperechogenicity of LN and
duration of botulinum toxin treatment. Similar results were also
reported by other investigators [
4,
21,
22].
This observation has important diagnostic implications because, as in
PD, the performance of a simple and widely available TCS test might be
useful adjunct to clinical diagnosis, which so far has been based on
clinical observations and negative results of additional tests [
23,
24].
Recent technological progress in the quality of the ultrasound image
allows for the more precise measurement of abnormalities deep within the
brain structure. In 2010, Gaenslen described unspecified
hyperechogenicity of the lenticular nuclei in more than 75% of patients
with cervical dystonia, in more than half of patients with other focal
dystonias and very rarely in patients with facial dystonia and
genetically determined dystonia [
21].
Other researchers confirmed more frequent occurrence of ultrasound TCS
changes of subcortical structures also in other neurodegenerative
diseases: multi-system atrophy, essential tremor, progressive
supranuclear palsy, corticobasal degeneration, neurodegeneration
associated with accumulation of iron, Huntington disease, Wilson
disease,
dementia with Lewy bodies, some spinocerebellar ataxias and restless legs syndrome [
23,
25-
28].
We did not find a correlation between the size of the observed changes
and dystonia severity or duration of the disease. The only correlation
was the association between the width of the third ventricle and age of
patients, which may correspond to the progression of regressive changes
of the brain associated with aging.
Recent studies with the use of magnetic resonance imaging (MRI),
specifically with diffusion tensor imaging, revealed the presence of
changes in the basal ganglia, thalamus, motor and premotor cortex,
cerebellum, frontal cortex, temporal cortex and parietal region, which
may be related to the hyperechogenic changes observed in TCS examination
in cervical dystonia [
6].
Volumetric MRI scans (voxel-based morphometry) revealed the presence of
structural changes in dystonia: volume increase of the gray matter of
the inner part of the globus pallidus, thalamus, cerebellum, primary
motor cortex, and supplementary motor cortex [
29,
30].
Reported findings are inconsistent, however, because the reduction of
the gray matter volume was also noted in the putamen, supplementary
motor cortex, right primary visual cortex and right dorsolateral
premotor cortex [
31-
33].
Diffusion tensor imaging delineates pathology of white matter fibres,
showing both macrostructural changes (diffusivity, as shown in apparent
diffusion coefficient [ADC]) and alterations of fibres organisation
(fractional anisotropy [FA]). In patients with inherited forms of
dystonia, some studies showed reduction of FA in sensorimotor cortex,
corpus callosum and increase in the putamen. Another study showed
reinforcement of diffusivity (ADC) within the striatum, globus pallidus
and caudate nucleus in dystonia.
Magnetisation transfer imaging detects relative proportions of free
protons and protons associated with macromolecules, showing changes in
the myelin and neuronal loss. These multifocal changes in structural
neuroimaging support the hypothesis that dystonia is one of the circuits
disorders of the basal ganglia resulting from pathologic disturbances
in neuronal activity throughout specific cortico-subcortical loops [
7]
but cannot show any marker specific for the diagnosis. The cause of
lenticular nucleus hyperechogenicity in primary dystonia is unclear.
However, post-mortem measurements of trace metals and calcium were
performed in brain tissue of 3 patients with adult-onset idiopathic
dystonia and 10 healthy controls and showed increased level of copper
and manganese in the dystonic patient compared with controls, whereas
there was no difference in the levels of iron, zinc, or calcium [
13].
Further analyses revealed that the level of the copper-metabolizing
Menkes protein was reduced, which could lead to increased levels of
copper in patients with primary dystonia. A subsequent study showed
decreased levels of mRNA for Menkes protein and reduced copper
concentrations in peripheral blood
lymphocytes in patients with cervical dystonia compared with patients with blepharospasm and healthy controls [
15]. This study suggests an alteration in copper metabolism in some forms of dystonia.
In 2005, Walter et al. [
13]
noted the presence of hyperechogenic changes in the lenticular nucleus
in 19 out of 21 patients with Wilson disease, i.e., the condition with
proven pathomechanism of copper metabolism disorder. This
hyperechogenicity of the lenticular nucleus appears as a dot and
resembles the TCS findings in idiopathic dystonia [
13].
In patients with Wilson disease associated with neurological
manifestation, the area of hyperechogenicity within the lenticular
nucleus is more extensive and correlates with disease severity, which
enables differential diagnosis of the metabolic disorders [
34].
It is probable that the hyperechogenic TCS changes in cervical dystonia
are also associated with excessive accumulation of copper [
13-
15], which might contribute to the pathogenesis of dystonia as a modulator of synaptic function and
neurotransmission. This early hypothesis requires further research, also because some studies do not confirm those observations [
35].
Our study, along with the previous ones, indicates a more frequent
occurrence of hyperechogenic changes in lenticular nuclei in primary
cervical dystonia [
22,
35].
We still do not know whether they differentiate the type of dystonia
and if they are associated with disease duration or depend on the time
and method of treatment. Perhaps their presence is a marker for the risk
of developing dystonia, which may be indicated by the observed presence
of hyperechogenic TCS changes in one healthy excluded subject with a
positive medical history towards dystonia. These questions, and the
observed high prevalence of changes within the basal ganglia, warrant
continued research. Undoubtedly, a weak point of the study might be not a
very large group of the patients and the ultrasounds were performed by
only one physician.
Conclusion
Beyond
the subjective image perception, the impact on results might be
performance of neuroimaging not at the same time as ultrasound. We
suggest that the observed ultrasound basal ganglia hyperechogenicity in
primary dystonia are associated with the pathogenesis of the disease,
and their location, taking the complex pathophysiological mechanism of
the disease into account, may be limited not only to the lenticular
nucleus and substantia nigra. It is likely that they also appear in
other brain structures; a thorough examination will allow us to
determine the different characteristic patterns for different types of
dystonia. In conclusion, we suggest that the hyperechogenic changes
within the lenticular nuclei are prevalent in patients with primary
cervical dystonia and are an important diagnostic clue.
References
- Geyer HL, Bressman SB (2006) The diagnosis of dystonia. Lancet Neurol 5: 780-790.
- Hallet M (2011) Neurophysiology of dystonia: the role of inhibition. Neurobiol Dis 42: 177-184.
- Lehericy S, Tijsen MA, Vidaihert M, Kaji R, Meunier S (2013) The anatomical basis of dystonia: Current view using neuroimaging. MovDisord 28: 944-957.
- BathiaKP, Marsden CD (1994) The behavioral and motor consequences of focal lesions of the basal ganglia in man. Brain 117: 859-876.
- Argyelan M, Carbon M, Niethammer M, Ulug AM, Voss HU, et al. (2009) Cerebellothalamocortical connectivity regulates penetrance in dystonia. J Neurosci 29: 9740-9747.
- Prell T, Peschel T, Kohler B, Bokemeyer MH, Dengler R, et al. (2013) Structural brain abnormalities in cervical dystonia. BMC Neurosci 16: 14-123.
- DeLong MR, Wichmann T (2007) Circuits and circuit disorders of the basal ganglia. Arch Neurol 64: 20-24.
- VitekJL (2002) Pathophysiology of dystonia: A neuronal model. MovDisord 17: S49-62.
- Berrardelli A, RothwellJC, Hallet M, Thompson PD, Manfredi M, et al. (1998) The pathophysiology of primary dystonia. Brain 121: 1195-212.
- Nauman
M, Becker G, Tikya KV, Supprian T, Reiners K (1996) Lenticular nucleus
lesion in idiopatic dystonia detected by transcranialsonography.
Neurology 47: 1284-1290.
- Tewari A, Fremont R, Khodakhak K (2017) It’s not just the basal ganglia: cerebellum as a target for dystonia therapeutics. MovDisord 32: 1537-1545.
- Defazio G, Berardelli A, Hallett M (2007) Do primary adult-onset focal dystonias share aetiological factors? Brain 130: 1183-1193.
- Becker G, Berg D, Rausch WD, Lange HK, Riederer P, et al. (1999) Increased tissue copper and manganese content in the lentiform nucleus in primary adult-onset dystonia. Ann Neurol46: 260-263.
- Berg
D, Weishaupt A, Francis MJ, Miura N, Yang XL, et al. (2000) Changes of
cooper-transporting proteins and ceruloplasmin in the lentiform nuclei
in primary adult-onset dystonia. Ann Neurol 47: 827-830.
- Kruse
N, Berg D, Francis MJ, Naumann M, Rausch WD, et al. (2001) Reduction in
Menkes mRNA and cooper in leukocytes of patients with primary
adult-onset dystonia. Ann Neurol 49: 405-408.
- Alberto A, Bhatia K, Bressman SB (2013) Phnomenology and classification of dystonia: A consensus update. MovDisord 28: 863-873.
- Albanese A, Asmus F, Bhatia KP, Elia AE, Elibol B, et al. (2011) EFNS guidelines ondiagnosis and treatment of primary dystonias. Eur J Neurol 18: 5-18.
- Becker
G, Seufert J, Bogdahn U, Reichmann H, Reiners K (1995) Degradation of
substantianigra in chronic Parkinson’s disease visualized by
transcranial color-coded real-time sonography. Neurology 45: 182-184.
- Bartova P, Skoloudik D, Bar M (2008) Transcranialsonography in movement disorders. Biomed pap Med FacUnivPalackyOlomounc Czech Rep 152: 251-258.
- Walter U, Skouloudik D (2014)
Transcranialsonography (TCS) of brain parenchyma in movement disorders:
quality standards, diagnostic applications and novel technologies.
Ultraschall Med 35: 322-331.
- Gaensler A (2010) Transcranialsonography in dystonia. Int Rev Neurobiol 90: 179-187.
- Zhang Y, Zhang YC, Sheng YJ (2016)
Sonographicalteration of basal ganglia in different forms ofprimary
focal dystonia: A cross-sectional study. Chin Med J (EN) 129: 942-945.
- Walter U, Dressler D, WoltersAIW(2006) Sonographic discrimination of dementia with Lewy bodies and Parkinsons disease with dementia. J. Neurol 253: 448-454.